Novo Nordisk Loses Challenge To Medicare Drug Price Talks

By Dan McKay · August 1, 2024, 5:39 PM EDT

Another challenge to a Medicare drug price negotiation program has failed after a New Jersey federal judge ruled once again that the program is voluntary and rejected claims that it violates...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

NOVO NORDISK INC. et al v. BECERRA et al

Case Number

3:23-cv-20814

Court

New Jersey

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

September 29, 2023

Recent Articles By Dan

November 19, 2024
No 'Tin Hats': Fluoride Ruling Offers Options As RFK Eyes Ban
November 15, 2024
Teva Defends Mifepristone Antitrust Case Against Corcept
November 12, 2024
Wash. Ballot Win Gives States Blueprint For 'Age Wave' Care
November 06, 2024
Voters Pass Medicaid Tax In Calif., Support IVF Coverage In Ill.
November 05, 2024
Biotech, Pharma Cos. Eye Impact Of DOJ's Foreign Data Rule
October 31, 2024
Beverly Hills Agrees To Abortion-Rights Training In Settlement
October 29, 2024
4th Circ. Quizzes Drugmaker Challenging W.Va. Abortion Law
October 29, 2024
Beyond Abortion, 7 Ballot Questions Set To Shape Care
October 23, 2024
NC Justices Scrutinize Scope Of Liability Shield In COVID Law
October 22, 2024
Drug-Shortage List Under Scrutiny After FDA Reversal